Page last updated: 2024-11-05

tranexamic acid and Femoral Neoplasms

tranexamic acid has been researched along with Femoral Neoplasms in 1 studies

Tranexamic Acid: Antifibrinolytic hemostatic used in severe hemorrhage.

Femoral Neoplasms: New abnormal growth of tissue in the FEMUR.

Research Excerpts

ExcerptRelevanceReference
"Tranexamic acid (TXA) has proven to be safe in elective and traumatic femoral hemiarthroplasty; however, itsĀ use has not been investigated in oncologic patients."1.62Use of tranexamic acid is not associated with complications following bipolar hemiarthroplasty for metastatic disease. ( Houdek, MT; Owen, A; Rose, PS; Wellings, EP; Wyles, CC; Yuan, BJ, 2021)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Owen, A1
Wellings, EP1
Wyles, CC1
Yuan, BJ1
Rose, PS1
Houdek, MT1

Other Studies

1 other study available for tranexamic acid and Femoral Neoplasms

ArticleYear
Use of tranexamic acid is not associated with complications following bipolar hemiarthroplasty for metastatic disease.
    Journal of surgical oncology, 2021, Volume: 123, Issue:4

    Topics: Antifibrinolytic Agents; Blood Loss, Surgical; Female; Femoral Neoplasms; Femur Neck; Follow-Up Stud

2021